journal
MENU ▼
Read by QxMD icon Read
search

Cost Effectiveness and Resource Allocation: C/E

journal
https://www.readbyqxmd.com/read/28603456/cost-effectiveness-analysis-of-the-diarrhea-alleviation-through-zinc-and-oral-rehydration-therapy-dazt-program-in-rural-gujarat-india-an-application-of-the-net-benefit-regression-framework
#1
Samuel D Shillcutt, Amnesty E LeFevre, Christa L Fischer-Walker, Sunita Taneja, Robert E Black, Sarmila Mazumder
BACKGROUND: This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework. METHODS: Costs were calculated from societal and caregivers' perspectives and effectiveness was assessed in terms of coverage of zinc and both zinc and Oral Rehydration Salt. Regression models were tested in simple linear regression, with a specified set of covariates, and with a specified set of covariates and interaction terms using linear regression with endogenous treatment effects was used as the reference case...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28559746/estimating-outcomes-and-cost-effectiveness-using-a-single-arm-clinical-trial-ofatumumab-for-double-refractory-chronic-lymphocytic-leukemia
#2
Anthony J Hatswell, Gwilym J Thompson, Penny A Maroudas, Oleg Sofrygin, Thomas E Delea
BACKGROUND: Ofatumumab (Arzerra(®), Novartis) is a treatment for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab [double refractory (DR-CLL)]. Ofatumumab was licensed on the basis of an uncontrolled Phase II study, Hx-CD20-406, in which patients receiving ofatumumab survived for a median of 13.9 months. However, the lack of an internal control arm presents an obstacle for the estimation of comparative effectiveness. METHODS: The objective of the study was to present a method to estimate the cost effectiveness of ofatumumab in the treatment of DR-CLL...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28484344/economic-evaluations-of-vaccines-in-canada-a-scoping-review
#3
REVIEW
Ellen R S Rafferty, Heather L Gagnon, Marwa Farag, Cheryl L Waldner
BACKGROUND: This study aims to summarise and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research. METHODS: Using Arksey and O'Malley's scoping review framework we assembled relevant research from both academic and grey literature. Following abstract and full-text review we identified 60 articles to be included in the final analysis. RESULTS: We found that since 1988 there has been a steady increase in the number of economic evaluations on vaccines in Canada...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28450811/efficiency-and-productivity-assessment-of-public-hospitals-in-greece-during-the-crisis-period-2009-2012
#4
P Xenos, J Yfantopoulos, M Nektarios, N Polyzos, P Tinios, A Constantopoulos
BACKGROUND: This study is an initial effort to examine the dynamics of efficiency and productivity in Greek public hospitals during the first phase of the crisis 2009-2012. Data were collected by the Ministry of Health after several quality controls ensuring comparability and validity of hospital inputs and outputs. Productivity is estimated using the Malmquist Indicator, decomposing the estimated values into efficiency and technological change. METHODS: Hospital efficiency and productivity growth are calculated by bootstrapping the non-parametric Malmquist analysis...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28428734/defining-a-staged-based-process-for-economic-and-financial-evaluations-of-mhealth-programs
#5
Amnesty E LeFevre, Samuel D Shillcutt, Sean Broomhead, Alain B Labrique, Tom Jones
Mobile and wireless technology for health (mHealth) has the potential to improve health outcomes by addressing critical health systems constraints that impede coverage, utilization, and effectiveness of health services. To date, few mHealth programs have been implemented at scale and there remains a paucity of evidence on their effectiveness and value for money. This paper aims to improve understanding among mHealth program managers and key stakeholders of how to select methods for economic evaluation (comparative analysis for determining value for money) and financial evaluation (determination of the cost of implementing an intervention, estimation of costs for sustaining or expanding an intervention, and assessment of its affordability)...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28413361/cost-effectiveness-analysis-of-the-national-decentralization-policy-of-antiretroviral-treatment-programme-in-zambia
#6
Shinsuke Miyano, Gardner Syakantu, Kenichi Komada, Hiroyoshi Endo, Tomohiko Sugishita
BACKGROUND: In resource-limited settings with a high prevalence of human immunodeficiency virus (HIV) infection such as Zambia, decentralization of HIV/acquired immunodeficiency syndrome (HIV/AIDS) treatment and care with effective use of resources is a cornerstone of universal treatment and care. OBJECTIVES: This research aims to analyse the cost effectiveness of the National Mobile Antiretroviral Therapy (ART) Services Programme in Zambia as a means of decentralizing ART services...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28400708/costs-and-savings-associated-with-a-pharmacists-prescribing-for-minor-ailments-program-in-saskatchewan
#7
Ellen Rafferty, Mohsen Yaghoubi, Jeff Taylor, Marwa Farag
BACKGROUND: Health care systems around the world have started to develop pharmacists prescribing for minor ailments (PPMA) programs. These programs aim to improve the efficiency of care, reduce physician visits, and increase the accessibility to prescription medication (Rx). This study performed an economic impact analysis of the pharmacists prescribing for minor ailments program in Saskatchewan. METHODS: We measured costs for the program and the alternative scenario (i...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28344517/economic-evaluation-of-participatory-learning-and-action-with-women-s-groups-facilitated-by-accredited-social-health-activists-to-improve-birth-outcomes-in-rural-eastern-india
#8
Rajesh Kumar Sinha, Hassan Haghparast-Bidgoli, Prasanta Kishore Tripathy, Nirmala Nair, Rajkumar Gope, Shibanand Rath, Audrey Prost
BACKGROUND: Neonatal mortality remains unacceptably high in many low and middle-income countries, including India. A community mobilisation intervention using participatory learning and action with women's groups facilitated by Accredited Social Health Activists (ASHAs) was conducted to improve maternal and newborn health. The intervention was evaluated through a cluster-randomised controlled trial conducted in Jharkhand and Odisha, eastern India. This aims to assess the cost-effectiveness this intervention...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28203120/international-lessons-in-new-methods-for-grading-and-integrating-cost-effectiveness-evidence-into-clinical-practice-guidelines
#9
REVIEW
Kathryn M Antioch, Michael F Drummond, Louis W Niessen, Hindrik Vondeling
Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of economic evidence in CPGs, and its integration into clinical practice and national decision making is hampered by objections from professions, paucity of economic evidence or lack of policy commitment. The use of state-of-art economic methodologies will improve this. Economic evidence can be graded by 'checklists' to establish the best evidence for decision making given methodological rigor...
2017: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/28035193/optimizing-treatment-for-the-prevention-of-pre-eclampsia-eclampsia-in-nepal-is-calcium-supplementation-during-pregnancy-cost-effective
#10
Isabelle Feldhaus, Amnesty E LeFevre, Chandra Rai, Jona Bhattarai, Deirdre Russo, Barbara Rawlins, Pushpa Chaudhary, Kusum Thapa
BACKGROUND: In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/E for pregnant women and preterm birth. This study presents findings from a cost-effectiveness analysis of a pilot project, which provided calcium supplementation through the public sector to pregnant women during antenatal care for PE/E prevention as compared to existing PE/E management in Nepal...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27999476/advancing-aged-care-a-systematic-review-of-economic-evaluations-of-workforce-structures-and-care-processes-in-a-residential-care-setting
#11
REVIEW
Tiffany Easton, Rachel Milte, Maria Crotty, Julie Ratcliffe
Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs and effectiveness of different workforce structures and care processes is important to facilitate the future planning of residential aged care services to promote high quality care and to enhance the quality of life of individuals living in residential care. A systematic review conducted up to December 2015 identified 19 studies containing an economic component; seven included a complete economic evaluation and 12 contained a cost analysis only...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27757069/what-are-we-paying-for-a-cost-effectiveness-analysis-of-patented-denosumab-and-generic-alendronate-for-postmenopausal-osteoporotic-women-in-australia
#12
Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji, Sofoora Kawsar Usman
OBJECTIVE: Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the price of the other two therapies has remained stable. Using data published since the listing, this paper reports current estimates of the value of denosumab compared to alendronate from an Australian health system perspective. METHODS: A cohort-based state transition model was developed that predicted changes in bone mineral density (BMD), and calibrated fracture probabilities as a function of BMD, age and previous fracture to estimate differences in costs and QALYs gained over a 10-year time horizon...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27524939/prevention-and-treatment-of-cardiovascular-disease-in-ethiopia-a-cost-effectiveness-analysis
#13
Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, Stéphane Verguet, Kjell Arne Johansson
BACKGROUND: The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia's meager healthcare budget, it is important to identify the most cost-effective interventions for further scale-up. This paper's objective is to assess cost-effectiveness of prevention and treatment of ischemic heart disease (IHD) and stroke in an Ethiopian setting. METHODS: Fifteen single interventions and sixteen intervention packages were assessed from a healthcare provider perspective...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27398070/an-extended-cost-effectiveness-analysis-of-schizophrenia-treatment-in-india-under-universal-public-finance
#14
Neha Raykar, Aditi Nigam, Dan Chisholm
BACKGROUND: Schizophrenia remains a priority condition in mental health policy and service development because of its early onset, severity and consequences for affected individuals and households. AIMS AND METHODS: This paper reports on an 'extended' cost-effectiveness analysis (ECEA) for schizophrenia treatment in India, which seeks to evaluate through a modeling approach not only the costs and health effects of intervention but also the consequences of a policy of universal public finance (UPF) on health and financial outcomes across income quintiles...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27274335/mothers-willingness-to-pay-for-hpv-vaccines-in-anambra-state-nigeria-a-cross-sectional-contingent-valuation-study
#15
Ifeoma Blessing Umeh, Sunday Odunke Nduka, Obinna Ikechukwu Ekwunife
BACKGROUND: Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are needed to sustain the government funded HPV vaccination programme. This study assessed Nigerian mothers' willingness-to-pay (WTP) for HPV vaccine. We also compared the difference between the average WTP and estimated costs of vaccinating a pre-adolescent girl (CVG). METHODS: We conducted a quantitative, cross-sectional, survey-based study in which 50 questionnaires were distributed to each of 10 secondary schools located in two rural and one urban city in Anambra state...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27081372/cost-utility-of-ranibizumab-versus-aflibercept-for-treating-greek-patients-with-visual-impairment-due-to-diabetic-macular-edema
#16
Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou, Nikos Maniadakis
BACKGROUND: To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting. METHODS: A Markov model was adapted to compare the use of ranibizumab 0.5 mg (pro re nata-PRN and treat and extend-T&E) to aflibercept 2 mg (every 8 weeks after five initial doses) in DME. Patients transitioned at a 3-month cycle among nine specified health states (including death) over a lifetime horizon...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/27006643/the-value-of-using-a-brain-laser-interstitial-thermal-therapy-litt-system-in-patients-presenting-with-high-grade-gliomas-where-maximal-safe-resection-may-not-be-feasible
#17
Jeffrey D Voigt, Gene Barnett
BACKGROUND: The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open resection (i.e. craniotomy) methods or biopsy (collectively termed CURRENT TREATMENTS) in patients where maximal safe resection may not be feasible. As has been demonstrated in the literature, extent of resection/ablation with minimal complications are independently related to overall survival...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/26973436/annual-acknowledgement-of-manuscript-reviewers
#18
Joan Rovira
The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/26893592/the-economic-burden-of-childhood-pneumococcal-diseases-in-the-gambia
#19
Effua Usuf, Grant Mackenzie, Sana Sambou, Deborah Atherly, Chutima Suraratdecha
BACKGROUND: Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a societal perspective, the costs incurred by health providers and families of children with pneumococcal diseases. METHODS: We recruited children less than 5 years of age with outpatient pneumonia, inpatient pneumonia, pneumococcal sepsis and bacterial meningitis at facilities in rural and urban Gambia...
2016: Cost Effectiveness and Resource Allocation: C/E
https://www.readbyqxmd.com/read/26848283/measuring-efficiency-of-governmental-hospitals-in-palestine-using-stochastic-frontier-analysis
#20
Samer Hamidi
BACKGROUND: The Palestinian government has been under increasing pressure to improve provision of health services while seeking to effectively employ its scare resources. Governmental hospitals remain the leading costly units as they consume about 60 % of governmental health budget. A clearer understanding of the technical efficiency of hospitals is crucial to shape future health policy reforms. In this paper, we used stochastic frontier analysis to measure technical efficiency of governmental hospitals, the first of its kind nationally...
2016: Cost Effectiveness and Resource Allocation: C/E
journal
journal
40406
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"